Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas

被引:49
作者
DiLoreto, C
Puglisi, F
Rimondi, G
Zuiani, C
Anania, G
DellaMea, V
Beltrami, CA
机构
[1] UNIV UDINE,DEPT PATHOL ANAT,I-33100 UDINE,ITALY
[2] UNIV UDINE,POSTGRAD SCH ONCOL,I-33100 UDINE,ITALY
[3] UNIV UDINE,DEPT RADIOL,I-33100 UDINE,ITALY
[4] UNIV UDINE,DEPT GEN SURG,I-33100 UDINE,ITALY
关键词
breast cancer; core biopsy; surgical pathology; prognosis; grading; steroid receptors; p53; c-erbB-2; immunohistochemistry;
D O I
10.1016/0959-8049(96)00192-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Large core biopsy is a recently introduced method for pre-operative evaluation of breast lumps. The aim of this study was to evaluate the usefulness of this technique in providing pre-operative diagnostic and prognostic information that can lead to a correct line of treatment. We compared 41 cases of breast carcinomas diagnosed both by core biopsies and surgically removed samples. A high (93%) diagnostic agreement was obtained. Moreover, we found a significant correlation for mitotic count (r = 0.76), oestrogen receptor (r = 0.78), progesterone receptor (r = 0.80), p53 (r = 0.86) and c-erbB-2 (r = 0.90) analysis between core biopsy and definitive surgical pathology. An agreement for histological grading evaluation between the two techniques was obtained in 32 out of 40 cases (k = 0.65) whereas in the other cases, a lower grade was assigned by evaluating core biopsies. These findings suggest that percutaneous core breast biopsy is a valid tool for pre-operative management of breast lesions, but this should be confirmed in larger, prospective studies. Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码:1693 / 1700
页数:8
相关论文
共 34 条
[1]   THE PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICAL ESTROGEN-RECEPTOR ANALYSIS IN PARAFFIN-EMBEDDED AND FROZEN-SECTIONS VERSUS THAT OF STEROID-BINDING ASSAYS [J].
ANDERSEN, J ;
THORPE, SM ;
KING, WJ ;
ROSE, C ;
CHRISTENSEN, I ;
RASMUSSEN, BB ;
POULSEN, HS .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (04) :442-449
[2]   PROGNOSTIC-SIGNIFICANCE OF TP53 ALTERATIONS IN BREAST-CARCINOMA [J].
ANDERSEN, TI ;
HOLM, R ;
NESLAND, JM ;
HEIMDAL, KR ;
OTTESTAD, L ;
BORRESEN, AL .
BRITISH JOURNAL OF CANCER, 1993, 68 (03) :540-548
[3]   IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IN MAMMARY-CARCINOMA - AN IMPORTANT NEW INDEPENDENT INDICATOR OF PROGNOSIS [J].
BARNES, DM ;
DUBLIN, EA ;
FISHER, CJ ;
LEVISON, DA ;
MILLIS, RR .
HUMAN PATHOLOGY, 1993, 24 (05) :469-476
[4]   LONG-TERM SURVIVAL IN BREAST-CANCER RELATED TO OVEREXPRESSION OF THE C-ERBB-2 ONCOPROTEIN - AN IMMUNOHISTOCHEMICAL STUDY USING MONOCLONAL-ANTIBODY NCL-CB11 [J].
DYKINS, R ;
CORBETT, IP ;
HENRY, JA ;
WRIGHT, C ;
YUAN, J ;
HENNESSY, C ;
LENNARD, TJW ;
ANGUS, B ;
HORNE, CHW .
JOURNAL OF PATHOLOGY, 1991, 163 (02) :105-110
[5]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[6]  
ELVECROG EL, 1993, RADIOLOGY, V164, P452
[7]   PROGNOSTIC-SIGNIFICANCE OF FLOW CYTOMETRIC DNA ANALYSIS AND ESTROGEN-RECEPTOR CONTENT IN BREAST CARCINOMAS - A 10 YEAR SURVIVAL STUDY [J].
EWERS, SB ;
ATTEWELL, R ;
BALDETORP, B ;
BORG, A ;
FERNO, M ;
LANGSTROM, E ;
KILLANDER, D .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 24 (02) :115-126
[8]  
FRIEDRICHS K, 1993, CANCER, V72, P3641, DOI 10.1002/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO
[9]  
2-8
[10]   TUMOR MICROVESSEL DENSITY, P53 EXPRESSION, TUMOR SIZE, AND PERITUMORAL LYMPHATIC VESSEL INVASION ARE RELEVANT PROGNOSTIC MARKERS IN NODE-NEGATIVE BREAST-CARCINOMA [J].
GASPARINI, G ;
WEIDNER, N ;
BEVILACQUA, P ;
MALUTA, S ;
DALLAPALMA, P ;
CAFFO, O ;
BARBARESCHI, M ;
BORACCHI, P ;
MARUBINI, E ;
POZZA, F .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :454-466